Last 7 days
4.1%
Last 30 days
5.1%
Last 90 days
0.1%
Trailing 12 Months
-10.1%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 56.7B | 56.0B | 55.1B | 0 |
2022 | 56.7B | 57.3B | 57.8B | 58.1B |
2021 | 50.2B | 53.7B | 55.2B | 56.2B |
2020 | 34.1B | 36.2B | 40.6B | 45.8B |
2019 | 32.6B | 32.6B | 32.9B | 33.3B |
2018 | 29.6B | 30.9B | 32.2B | 32.8B |
2017 | 26.2B | 26.7B | 27.3B | 28.2B |
2016 | 23.8B | 24.8B | 25.2B | 25.6B |
2015 | 20.4B | 21.0B | 21.9B | 22.9B |
2014 | 19.0B | 19.3B | 19.6B | 20.0B |
2013 | 18.5B | 18.7B | 18.9B | 18.8B |
2012 | 17.7B | 17.9B | 18.1B | 18.4B |
2011 | 16.1B | 16.5B | 17.0B | 17.4B |
2010 | 0 | 0 | 0 | 15.6B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 25, 2023 | gonzalez richard a | gifted | - | - | -42,000 | chairman of the board and ceo |
Sep 07, 2023 | alpern robert j | acquired | - | - | 129 | - |
Aug 01, 2023 | gonzalez richard a | sold | -8,914,800 | 148 | -60,000 | chairman of the board and ceo |
Jul 31, 2023 | gonzalez richard a | sold | -2,759,280 | 149 | -18,500 | chairman of the board and ceo |
May 11, 2023 | strom carrie c | sold (taxes) | -421,104 | 146 | -2,876 | svp & pres global allerg aesth |
May 05, 2023 | burnside william h.l. | acquired | - | - | 1,450 | - |
May 05, 2023 | austin roxanne s | acquired | - | - | 1,450 | - |
May 05, 2023 | alpern robert j | acquired | - | - | 1,450 | - |
May 05, 2023 | freyman thomas c | acquired | - | - | 1,450 | - |
May 05, 2023 | roberts rebecca b | acquired | - | - | 1,450 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 07, 2023 | DAGCO, INC. | added | 0.08 | 121,925 | 1,258,060 | 0.65% |
Dec 07, 2023 | Financial Advisory Group | unchanged | - | 60,874 | 633,207 | 0.13% |
Dec 07, 2023 | Hudson Bay Capital Management LP | added | 27.39 | 18,234,500 | 62,769,800 | 0.25% |
Dec 06, 2023 | CITIGROUP INC | reduced | -13.16 | -17,819,400 | 435,950,000 | 0.33% |
Dec 06, 2023 | Grant Street Asset Management, Inc. | reduced | -1.99 | 40,571 | 521,513 | 0.21% |
Dec 06, 2023 | Fragasso Group Inc. | added | 1.5 | 198,082 | 1,810,150 | 0.19% |
Dec 06, 2023 | Raleigh Capital Management Inc. | added | 0.06 | 237,057 | 2,450,950 | 1.30% |
Dec 06, 2023 | VisionPoint Advisory Group, LLC | added | 2.13 | 164,954 | 1,434,520 | 0.62% |
Dec 05, 2023 | Advisory Resource Group | reduced | -10.26 | -2,058 | 290,683 | 0.08% |
Dec 05, 2023 | Morton Capital Management LLC/CA | added | 0.68 | 144,118 | 1,410,360 | 0.50% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 16, 2023 | blackrock inc. | 7.8% | 138,702,758 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.95% | 158,317,552 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.28% | 146,312,069 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.3% | 128,197,555 | SC 13G/A | |
Feb 16, 2021 | capital research global investors | 2.1% | 37,921,062 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.08% | 142,563,074 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.0% | 124,423,484 | SC 13G/A | |
Feb 14, 2020 | capital research global investors | 5.8% | 86,602,693 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.28% | 122,574,720 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 6.7% | 98,593,810 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 06, 2023 | 8-K | Current Report | |
Nov 30, 2023 | 8-K | Current Report | |
Nov 15, 2023 | 25-NSE | 25-NSE | |
Nov 06, 2023 | 10-Q | Quarterly Report | |
Oct 27, 2023 | 8-K | Current Report | |
Oct 19, 2023 | 3 | Insider Trading | |
Oct 19, 2023 | 3 | Insider Trading | |
Oct 12, 2023 | 8-K | Current Report | |
Oct 04, 2023 | 8-K | Current Report | |
Oct 03, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 389.5B | 102.8B | 2.69% | -12.25% | 11.25 | 3.79 | 11.47% | 80.74% |
MRK | 272.8B | 59.3B | -0.63% | -5.14% | 17.88 | 4.63 | 0.58% | -69.80% |
PFE | 162.5B | 68.5B | -6.62% | -44.42% | 15.5 | 2.37 | -31.38% | -64.79% |
AMGN | 144.0B | 26.8B | -1.52% | -4.93% | 19.03 | 5.37 | 1.91% | 10.69% |
GILD | 98.5B | 27.4B | 1.44% | -10.10% | 16.77 | 3.6 | 0.94% | 76.21% |
MID-CAP | ||||||||
TEVA | 11.0B | 15.3B | 7.32% | 18.03% | -4.98 | 0.72 | 0.87% | -71.24% |
ALKS | 4.3B | 1.6B | 4.36% | 1.49% | 20.08 | 2.71 | 40.56% | 266.27% |
PRGO | 4.0B | 4.7B | 2.10% | -7.72% | -978.12 | 0.86 | 5.74% | 96.18% |
AMPH | 2.7B | 601.3M | 24.99% | 94.42% | 20.1 | 4.52 | 24.02% | 75.17% |
BHC | 2.7B | 8.5B | 1.81% | -4.07% | -2.77 | 0.31 | 5.11% | -479.13% |
SMALL-CAP | ||||||||
TLRY | 1.4B | 650.9M | 10.34% | -28.86% | -0.96 | 2.13 | 6.08% | -185.21% |
TXMD | 22.1M | - | -5.00% | -65.05% | 0.32 | 0.55 | -19.54% | 888.31% |
ACOR | 15.2M | 111.1M | 27.41% | 2089.90% | -0.96 | 0.14 | -10.43% | 84.90% |
ACRX | 12.5M | - | 39.62% | -61.05% | -0.59 | 0.13 | 287.27% | -145.15% |
AGRX | 5.2M | 20.0M | 16.16% | 1110.53% | -0.38 | 0.26 | 137.71% | 66.04% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 0.4% | 13,927 | 13,865 | 12,225 | 15,121 | 14,812 | 14,583 | 13,538 | 14,886 | 14,342 | 13,959 | 13,010 | 13,858 | 12,902 | 10,425 | 8,619 | 8,704 | 8,479 | 8,255 | 7,828 | 8,305 | 8,236 |
Costs and Expenses | 24.5% | 11,646 | 9,352 | 9,457 | 9,619 | 10,209 | 11,288 | 8,821 | 9,812 | 10,036 | 9,518 | 8,907 | 10,105 | 9,647 | 9,673 | 5,016 | 4,748 | 5,862 | 4,855 | 4,818 | 10,746 | 5,077 |
S&GA Expenses | 3.2% | 3,372 | 3,268 | 3,039 | 3,417 | 3,304 | 5,412 | 3,127 | 3,260 | 3,083 | 3,164 | 2,842 | 3,231 | 2,846 | 3,527 | 1,695 | 1,951 | 1,657 | 1,654 | 1,680 | 1,929 | 1,919 |
EBITDA Margin | -20.5% | 0.16* | 0.20* | 0.22* | 0.29* | - | 0.26* | 0.31* | 0.29* | - | - | 0.14* | 0.13* | 0.24* | 0.26* | 0.32* | 0.31* | 0.13* | 0.15* | - | - | - |
Income Taxes | -70.5% | 172 | 583 | 234 | 493 | 448 | 255 | 436 | 226 | 508 | 394 | 312 | -1,545 | 187 | 46.00 | 88.00 | 273 | 117 | 66.00 | 88.00 | -547 | 14.00 |
Earnings Before Taxes | -25.2% | 1,953 | 2,610 | 475 | 2,965 | 4,400 | 1,183 | 4,929 | 4,271 | 3,688 | 1,163 | 3,867 | -1,507 | 2,500 | -693 | 3,098 | 3,074 | 2,001 | 807 | 2,544 | -2,373 | 2,761 |
EBT Margin | -22.2% | 0.15* | 0.19* | 0.16* | 0.23* | 0.26* | 0.25* | 0.25* | 0.23* | 0.13* | 0.11* | 0.08* | 0.07* | 0.20* | 0.21* | 0.26* | - | - | - | - | - | - |
Net Income | -12.2% | 1,778 | 2,024 | 239 | 2,473 | 3,949 | 924 | 4,490 | 4,044 | 3,179 | 766 | 3,553 | 36.00 | 2,308 | -738 | 3,010 | 2,801 | 1,884 | 741 | 2,456 | -1,826 | 2,747 |
Net Income Margin | -23.8% | 0.12* | 0.16* | 0.13* | 0.20* | 0.23* | 0.22* | 0.22* | 0.21* | 0.14* | 0.12* | 0.10* | 0.10* | 0.18* | 0.19* | 0.25* | - | - | - | - | - | - |
Free Cashflow | 19.8% | 7,355 | 6,141 | 4,018 | 7,215 | 7,425 | 4,862 | 4,746 | 4,888 | 7,718 | 4,695 | 4,689 | 4,575 | 5,613 | 2,912 | 3,690 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 0.6% | 136,221 | 135,367 | 134,544 | 138,805 | 141,325 | 143,186 | 143,211 | 146,529 | 148,858 | 147,972 | 150,501 | 150,565 | 149,621 | 149,530 | 91,199 | 89,115 | 59,441 | 57,142 | 56,769 | 59,352 | 66,164 |
Current Assets | 15.2% | 33,224 | 28,852 | 26,488 | 28,463 | 30,364 | 29,100 | 26,509 | 27,928 | 28,957 | 25,999 | 26,569 | 24,173 | 23,009 | 21,256 | 51,758 | 49,519 | 20,166 | 15,100 | 14,413 | 16,945 | 18,465 |
Cash Equivalents | 51.7% | 13,287 | 8,759 | 6,711 | 9,201 | 11,832 | 8,521 | 6,098 | 9,746 | 12,182 | 8,546 | 9,755 | 8,449 | 7,890 | 6,017 | 41,142 | 39,924 | 10,648 | 5,172 | 4,897 | 7,289 | 8,015 |
Inventory | -1.8% | 3,981 | 4,055 | 3,833 | 3,579 | 3,172 | 3,396 | 3,483 | 3,128 | 3,094 | 3,386 | 3,272 | 3,310 | 3,474 | 4,059 | 1,844 | 1,813 | 1,929 | 1,895 | 1,702 | 1,605 | 1,786 |
Net PPE | -0.2% | 4,934 | 4,943 | 4,931 | 4,935 | 4,893 | 4,958 | 5,075 | 5,110 | 5,130 | 5,161 | 5,193 | 5,248 | 4,986 | 4,908 | 2,961 | 2,962 | 2,894 | 2,879 | 2,860 | 2,883 | 2,950 |
Goodwill | -0.4% | 32,091 | 32,224 | 32,220 | 32,156 | 31,726 | 32,028 | 32,298 | 32,379 | 32,296 | 32,398 | 32,349 | 33,124 | 42,801 | 42,669 | 15,561 | 15,604 | 15,537 | 15,642 | 15,606 | 15,663 | 15,718 |
Current Liabilities | 7.9% | 34,773 | 32,239 | 27,590 | 29,538 | 32,712 | 34,473 | 32,521 | 35,194 | 28,533 | 28,684 | 31,951 | 28,661 | 24,181 | 24,646 | 16,471 | 15,585 | 17,493 | 16,941 | 13,904 | 17,239 | 15,387 |
Short Term Borrowings | - | 2.00 | - | 1.00 | 1.00 | 10.00 | 17.00 | 12.00 | 14.00 | 16.00 | 17.00 | 9.00 | 34.00 | 54.00 | 64.00 | 6.00 | - | - | 306 | 499 | 3,699 | 3,002 |
Long Term Debt | -0.3% | 55,631 | 55,812 | 59,292 | 59,135 | 60,399 | 61,002 | 63,522 | 64,189 | 74,049 | 74,237 | 74,183 | 77,554 | 82,282 | 82,061 | 63,284 | 62,975 | 33,126 | 31,619 | 35,066 | 35,002 | 36,487 |
Shareholder's Equity | -5.7% | 12,129 | 12,866 | 13,303 | 17,254 | 15,994 | 14,688 | 16,314 | 15,436 | 13,577 | 12,594 | 13,733 | 13,097 | 15,289 | 14,732 | - | - | - | - | - | - | - |
Retained Earnings | -47.8% | 933 | 1,789 | 2,393 | 4,784 | 4,953 | 3,516 | 5,103 | 3,127 | 1,600 | 740 | 2,292 | 1,055 | 3,335 | 3,130 | 5,973 | 4,717 | 3,673 | 3,384 | 4,234 | 3,368 | 6,789 |
Additional Paid-In Capital | 0.9% | 20,021 | 19,839 | 19,619 | 19,245 | 19,056 | 18,906 | 18,731 | 18,305 | 18,108 | 17,936 | 17,712 | 17,384 | 17,148 | 16,953 | 15,401 | 15,193 | 15,112 | 15,028 | 14,940 | 14,756 | 14,680 |
Shares Outstanding | -100.0% | - | 1,767 | 1,770 | - | 1,771 | 1,770 | 1,771 | - | 1,770 | 1,769 | 1,769 | - | 1,769 | 1,647 | 1,481 | - | 1,481 | 1,480 | 1,480 | - | 1,511 |
Minority Interest | 9.4% | 35.00 | 32.00 | 29.00 | 33.00 | 33.00 | 35.00 | 31.00 | 28.00 | 27.00 | 25.00 | 23.00 | 21.00 | 19.00 | 24.00 | - | - | - | - | - | - | - |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 19.9% | 7,574 | 6,319 | 4,193 | 7,428 | 7,602 | 5,005 | 4,908 | 5,075 | 7,935 | 4,890 | 4,877 | 4,854 | 5,830 | 3,089 | 3,815 | 3,275 | 4,555 | 2,477 | 3,017 | 3,392 | 4,524 |
Share Based Compensation | -27.4% | 130 | 179 | 313 | 132 | 126 | 107 | 306 | 129 | 135 | 159 | 269 | 136 | 162 | 236 | 219 | 79.00 | 75.00 | 87.00 | 189 | 70.00 | 75.00 |
Cashflow From Investing | -8.2% | -369 | -341 | -499 | -448 | 1,286 | 130 | -1,591 | -1,145 | -615 | -242 | -342 | -627 | -1,149 | -35,652 | -129 | -615 | 1,378 | -140 | -27.00 | -283 | -963 |
Cashflow From Financing | 32.1% | -2,661 | -3,920 | -6,192 | -9,634 | -5,518 | -2,679 | -6,972 | -6,338 | -3,643 | -5,884 | -3,174 | -3,695 | -2,814 | -2,570 | -2,422 | 26,602 | -441 | -2,070 | -5,383 | -3,825 | 916 |
Dividend Payments | 0.1% | 2,627 | 2,625 | 2,661 | 2,506 | 2,504 | 2,507 | 2,526 | 2,314 | 2,315 | 2,310 | 2,322 | 2,101 | 2,100 | 1,752 | 1,763 | 1,595 | 1,591 | 1,592 | 1,588 | 1,451 | 1,461 |
Buy Backs | -60.0% | 4.00 | 10.00 | 1,955 | 4.00 | 4.00 | 9.00 | 1,470 | 131 | 6.00 | 10.00 | 787 | 296 | 20.00 | 19.00 | 643 | 2.00 | 4.00 | 3.00 | 620 | 2,058 | 1,009 |
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net revenues | $ 13,927 | $ 14,812 | $ 40,017 | $ 42,933 |
Cost of products sold | 6,485 | 5,022 | 14,711 | 13,244 |
Selling, general and administrative | 3,372 | 3,304 | 9,679 | 11,843 |
Research and development | 1,723 | 1,614 | 5,748 | 4,720 |
Acquired IPR&D and milestones | 66 | 40 | 496 | 454 |
Other operating expense (income), net | 0 | 229 | (179) | 57 |
Total operating costs and expenses | 11,646 | 10,209 | 30,455 | 30,318 |
Operating earnings | 2,281 | 4,603 | 9,562 | 12,615 |
Interest expense, net | 398 | 497 | 1,306 | 1,568 |
Net foreign exchange loss | 25 | 36 | 97 | 108 |
Other expense (income), net | (95) | (330) | 3,121 | 427 |
Earnings before income tax expense | 1,953 | 4,400 | 5,038 | 10,512 |
Income tax expense | 172 | 448 | 989 | 1,139 |
Net earnings | 1,781 | 3,952 | 4,049 | 9,373 |
Net earnings attributable to noncontrolling interest | 3 | 3 | 8 | 10 |
Net earnings attributable to AbbVie Inc. | $ 1,778 | $ 3,949 | $ 4,041 | $ 9,363 |
Per share data | ||||
Basic earnings per share (in dollars per share) | $ 1.00 | $ 2.22 | $ 2.27 | $ 5.26 |
Diluted earnings per share (in dollars per share) | $ 1.00 | $ 2.21 | $ 2.26 | $ 5.24 |
Weighted-average basic shares outstanding (in shares) | 1,767 | 1,771 | 1,768 | 1,771 |
Weighted-average diluted shares outstanding (in shares) | 1,771 | 1,776 | 1,772 | 1,777 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and equivalents | $ 13,287 | $ 9,201 |
Short-term investments | 3 | 28 |
Accounts receivable, net | 11,412 | 11,254 |
Inventories | 3,981 | 3,579 |
Prepaid expenses and other | 4,541 | 4,401 |
Total current assets | 33,224 | 28,463 |
Investments | 275 | 241 |
Property and equipment, net | 4,934 | 4,935 |
Intangible assets, net | 58,603 | 67,439 |
Goodwill | 32,091 | 32,156 |
Other assets | 7,094 | 5,571 |
Total assets | 136,221 | 138,805 |
Current liabilities | ||
Short-term borrowings | 2 | 1 |
Current portion of long-term debt and finance lease obligations | 5,113 | 4,135 |
Accounts payable and accrued liabilities | 29,658 | 25,402 |
Total current liabilities | 34,773 | 29,538 |
Long-term debt and finance lease obligations | 55,631 | 59,135 |
Deferred income taxes | 2,044 | 2,190 |
Other long-term liabilities | 31,644 | 30,655 |
Commitments and contingencies | ||
Stockholders' equity | ||
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,822,577,212 shares issued as of September 30, 2023 and 1,813,770,294 as of December 31, 2022 | 18 | 18 |
Common stock held in treasury, at cost, 57,091,177 shares as of September 30, 2023 and 44,589,000 as of December 31, 2022 | (6,525) | (4,594) |
Additional paid-in capital | 20,021 | 19,245 |
Retained earnings | 933 | 4,784 |
Accumulated other comprehensive loss | (2,353) | (2,199) |
Total stockholders' equity | 12,094 | 17,254 |
Noncontrolling interest | 35 | 33 |
Total equity | 12,129 | 17,287 |
Total liabilities and equity | $ 136,221 | $ 138,805 |
CEO | Mr. Richard A. Gonzalez |
---|---|
WEBSITE | www.abbvie.com |
EMPLOYEES | 50000 |